Corbion Welcomes Per Falholt to Its Supervisory Board in 2026
Corbion Nominates Per Falholt for Supervisory Board Appointment
Corbion's Supervisory Board has announced the nomination of Per Falholt for a four-year term as a member of the Supervisory Board, starting from the upcoming Annual General Meeting of Shareholders (AGM) in May 2026.
Experience and Background of Per Falholt
Mr. Falholt, a Danish national, boasts over 40 years of extensive experience in the realms of research and development, innovation, and leadership specifically targeting the biotechnology and life sciences sectors. Presently, he works as an Operating Partner at the Netherlands-based venture capital firm Forbion and is a co-founder as well as Chief Scientific Officer at 21st.BIO. His track record includes significant roles such as the Chairman of the Board at DHI Foundation and Board Member positions at CO-RO A/S and Danfoss A/S. Prior to these roles, he served as the Executive Vice President and Global Manager of R&D at Novozymes, overseeing global R&D strategies and innovations. He holds a Master's Degree in Chemical Engineering from the Technical University of Denmark.
Chairperson's Statement on the Appointment
Ilona Haaijer, Chair of the Supervisory Board, expressed enthusiasm regarding Mr. Falholt's nomination: "We are thrilled to welcome Per Falholt to our Supervisory Board. His extensive experience in R&D and innovation, coupled with strong leadership skills and a solid academic foundation, is invaluable as we continue to propel our strategic initiatives forward at Corbion. We are confident that Per's insights will significantly enhance our value creation efforts."
Transition Timeline and Future Planning
Mr. Falholt will begin his advisory role with the Supervisory Board on October 1, 2025, paving the way for his full appointment. This decision comes as Mr. Steen Riisgaard will step down due to ineligibility for reappointment post-AGM 2026.
Following the approval by the AGM, Mr. Falholt's official appointment will take effect at the conclusion of the AGM in May 2026. The detailed agenda for the AGM will be disclosed in April 2026 to ensure all stakeholders are informed and prepared.
Frequently Asked Questions
Who is Per Falholt?
Per Falholt is a Danish national with over 40 years of experience in R&D and leadership in biotechnology and life sciences, nominated for Corbion's Supervisory Board.
When will Per Falholt officially join the Supervisory Board?
Per Falholt's appointment is set to become official at the conclusion of the AGM in May 2026.
What are Per Falholt's qualifications?
Mr. Falholt holds a Master's Degree in Chemical Engineering and has held significant positions in several organizations within the biotechnology sector.
What did the Chair of the Supervisory Board say about Per Falholt?
Ilona Haaijer welcomed him warmly, noting his extensive experience and how his insights will enhance the company’s strategic initiatives at Corbion.
What is the role of the Supervisory Board?
The Supervisory Board oversees and guides the company's management, providing strategic direction and ensuring that shareholder interests are represented.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
